Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy

Endocrine therapy is increasingly understood as the conceptual basis for the future treatment and prevention of breast cancer. Endocrine agents have considerably changed the approach to targeted treatment during the past two decades, and select endocrine agents have advanced the goal of preventing b...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig Jordan, V, Ponder, Bruce AJ
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314406/
https://www.ncbi.nlm.nih.gov/pubmed/14580241
_version_ 1782121112672403456
author Craig Jordan, V
Ponder, Bruce AJ
author_facet Craig Jordan, V
Ponder, Bruce AJ
author_sort Craig Jordan, V
collection PubMed
description Endocrine therapy is increasingly understood as the conceptual basis for the future treatment and prevention of breast cancer. Endocrine agents have considerably changed the approach to targeted treatment during the past two decades, and select endocrine agents have advanced the goal of preventing breast cancer. Progress has occurred because of a vigorous interaction between laboratory scientists and the clinical trials community. Breast Cancer Research is launching a new section on endocrinology and hormone therapy in order to invigorate this exchange and challenge our readers with novel concepts that might result in enhanced survival in breast cancer.
format Text
id pubmed-314406
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-3144062004-01-17 Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy Craig Jordan, V Ponder, Bruce AJ Breast Cancer Res Editorial Endocrine therapy is increasingly understood as the conceptual basis for the future treatment and prevention of breast cancer. Endocrine agents have considerably changed the approach to targeted treatment during the past two decades, and select endocrine agents have advanced the goal of preventing breast cancer. Progress has occurred because of a vigorous interaction between laboratory scientists and the clinical trials community. Breast Cancer Research is launching a new section on endocrinology and hormone therapy in order to invigorate this exchange and challenge our readers with novel concepts that might result in enhanced survival in breast cancer. BioMed Central 2003 2003-08-26 /pmc/articles/PMC314406/ /pubmed/14580241 Text en Copyright © 2003 BioMed Central Ltd
spellingShingle Editorial
Craig Jordan, V
Ponder, Bruce AJ
Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title_full Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title_fullStr Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title_full_unstemmed Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title_short Introducing a new section to Breast Cancer Research: Endocrinology and hormone therapy
title_sort introducing a new section to breast cancer research: endocrinology and hormone therapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314406/
https://www.ncbi.nlm.nih.gov/pubmed/14580241
work_keys_str_mv AT craigjordanv introducinganewsectiontobreastcancerresearchendocrinologyandhormonetherapy
AT ponderbruceaj introducinganewsectiontobreastcancerresearchendocrinologyandhormonetherapy

Ejemplares similares